{"id":"W2120639027","doi":"10.1016/s1470-2045(12)70525-9","title":"Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial","year":2012,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":223,"is_retracted":false,"has_abstract":false,"ca_institutions":"Translational Research in Oncology; Hôpital du Saint-Sacrement; Essar Steel Algoma (Canada); Dr. H. Bliss Murphy Cancer Centre; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Breast cancer; Internal medicine; Docetaxel; Hazard ratio; Anthracycline; Cyclophosphamide; Clinical endpoint; Taxane; Cancer; Chemotherapy; Oncology; Surgery; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004951371,0.0002001647,0.0005795622,0.0000225035,0.0001043226,0.000005858634,0.000253914,0.0001416563,0.00007899378],"category_scores_gemma":[0.00007668021,0.0001155728,0.0001055385,0.0001134637,0.0003472769,0.00000721845,0.0002150022,0.0001400153,0.000004712514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000879911,"about_ca_system_score_gemma":0.000127007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005905054,"about_ca_topic_score_gemma":0.0005917834,"domain_scores_codex":[0.9985883,0.0003393174,0.0002815928,0.0002464387,0.0001166007,0.000427812],"domain_scores_gemma":[0.9991568,0.0001320036,0.0002160996,0.0003708152,0.00006703044,0.00005719205],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7567268,0.002228823,0.09601332,0.00008362196,0.001489587,0.00001116445,0.002835163,0.0000382026,0.07857207,0.0003321554,0.0231416,0.0385275],"study_design_scores_gemma":[0.7640262,0.0008240457,0.1612786,0.00007018419,0.0004353098,0.00008468302,0.0004140574,0.000009194256,0.04337011,0.0001024707,0.02903635,0.0003488554],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891178,0.003801215,0.000006368596,0.003587162,0.000771025,0.0007610992,0.0003469423,0.000007837726,0.001600551],"genre_scores_gemma":[0.99606,0.001717311,0.00003884321,0.00070062,0.0009495168,0.0002288877,0.00003543659,0.00001783073,0.0002515695],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06526528,"threshold_uncertainty_score":0.4712922,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01830545395135363,"score_gpt":0.3107389978638279,"score_spread":0.2924335439124743,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}